Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal

Retrieved on: 2022-09-06 10:12:24

Tags for this article:

Click the tags to see associated articles and topics

Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal. View article details on hiswai:

Excerpt

Synaffix to provide access to proprietary ADC technologies (GlycoConnect™, HydraSpace™ and exatecan-based SYNtecan E™ linker-payload)Emergence ...

Article found on: www.benzinga.com